Medical ＆ Biological Laboratories Co., Ltd. (MBL), a JSR Life Sciences Company, announced on April 4, 2022 launch of a new kit for the detection of anti-Integrin αvβ6 antibodies.

For more information on ‘Launch of a New Kit for the Detection of anti-Integrin αvβ6 Antibodies’, visit MBL's webpage on the new service.
https://www.mblbio.com/e/ir/2022/img/Press20220404E.pdf